Research recommendation(s) from an individual piece of guidance
|Guidance:||Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer|
|Date issued:||August 2012|
Research recommendations coming out of this guidance
- Studies exploring the effectiveness of bevacizumab in people previously treated with a taxane and its effects on health-related quality of life.
This page was last updated: 20 March 2014